Pregled bibliografske jedinice broj: 917478
Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings
Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings // International Journal of Surgery, 12 (2014), 11; 1167-1171 doi:10.1016/j.ijsu.2014.07.275 (međunarodna recenzija, članak, ostalo)
CROSBI ID: 917478 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings
Autori
Zovak, Mario ; Boban, Marko ; Boban, Ljubica ; Cicek, Silvio ; Madzar, Zrinko ; Belev, Borislav ; Tomas, Davor
Izvornik
International Journal of Surgery (1743-9191) 12
(2014), 11;
1167-1171
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
Gastrointestinal stromal tumor (GIST), Surgical treatment, Complete resection, Ki-67, Adjuvant treatment, Imatinib
Sažetak
OBJECTIVE: Despite significant improvement in survival of gastrointestinal stromal tumors (GIST) due to use of tyrosine kinase inhibitors, surgery still represents the important part of clinical management. The aim of our study was to retrospectively analyze prognosis of GIST depending on the success of surgical treatments and utilization of chemotherapy in transitional country with relatively limited resources. METHODS: cohort of consecutive patients operated for GIST in tertiary medical center, within time frame 1999-2012. RESULTS: 54 patients, in age range 20-85 years (63.3 ± 14.7), male to female ratio 28 (51.9%):26 (48.1%), respectively. Complete excision with clean resection margins (R0) was obtained in 44 (81.5%)of total patients i.e. 44/47 (93.6%) of localized GISTs. Mean follow up was 3.9 ± 3.3 years and 19 patients (35.2%) received imatinib. Rate of overall survival was 40 (74.1%), disease-free survival 31 (57.4%) and 20 (37.0%) experienced recidivism. Follow-up parameters showed significant difference in connection with utilization of imatinib, completeness of resection and existence of metastatic disease (all p < 0.05). ROC analyzes revealed critical value of Ki-67 > 9% as significant predictor of long-term mortality ; sensitivity 64.3% [95%CI = 35.1-87.2] ; specificity 75.0% [58.8-87.3] ; (AUC = 0.693 ; p = 0.049). CONCLUSION: Rate of complete resections in studied sample of patients from transitional background was overall peer comparable with reports from the developed countries. On the other hand, relatively dominant prognostic position of surgical treatments might be consequence of limited utilization of adjuvant treatment with tyrosine kinase inhibitors.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Medicinski fakultet, Osijek
Profili:
Borislav Belev
(autor)
Davor Tomas
(autor)
Marko Boban
(autor)
Zrinko Madžar
(autor)
Mario Zovak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE